Aurora Cannabis (TSX:ACB) Revenue Falls 26%: Time to Sell the Stock?

This past week, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) released its earnings for the second quarter of 2020, and they were, predictably, bad. The company reported a 26% drop in net revenue along with a colossal $1.3 billion GAAP net loss. While the net loss was mostly due to a goodwill impairment charge, the company also reported a $80 million adjusted EBITDA loss that…

Read More

HEXO (TSX:HEXO) Abruptly Changes Auditors: Should Investors Raise Eyebrows?

HEXO Corp (TSX:HEXO)(NYSE:HEXO) announced on Friday, February 7 that it had changed its auditors effective January 31, 2020, and this could raise some investor concerns, considering the cannabis firm was recently “pressured” to restate its earnings. The company has changed its auditors from MNP LLP to PricewaterhouseCoopers LLP, and there has been no statutorily required reportable events upon the change,…

Read More

Namaste Technologies (TSXV:N) Stock Doubles in 3 Weeks! Is There Further Upside?

Online cannabis retailer Namaste Technologies’s (TSXV:N) stock price has apparently doubled in the first three weeks of 2020 after a strong 23% surge on Wednesday raised the year-to-date return to 106% at end of day. This all happened without any company-specific news on the day. This is a strong recovery since trade in the company’s shares touched a 52-week low…

Read More

Is HEXO Stock a Buy After Restated Earnings?

Cannabis producer HEXO’s (TSX:HEXO)(NYSE:HEXO) stock has been on a strong rebound lately since the start of the new year and the share price closed nearly 16% higher on Wednesday as the pot industry received an Organigram Holdings powered valuation boost. The company recently filed restated financial reports for its fiscal year which ended July 31, 2019 as well as amended…

Read More

Will Aphria’s (TSX:APHA) Stock Tank if Q2 Earnings Miss?

Aphria (TSX:APHA)(NYSE:APHA) was one of the better-performing cannabis stocks of 2019. Although its stock declined in value for the year, it fell less than most of its peers thanks to two consecutive quarters of positive net income. Aphria’s positive earnings results in 2019 were a surprise to most investors. Cannabis stocks had broadly been expected to lose money, and few expected…

Read More

3 Top Canadian Cannabis Stocks to Watch This Month

Investors in Canadian marijuana stocks are looking forward to the first industry earnings release of 2020 from Aphria (TSX:APHA)(NYSE:APHA) and two other local players expected to report this month. Here’s what’s to watch on each report and why. Aphria Aphria stock rose over 22% in a day after an earnings beat in October last year, and the company is expected…

Read More

Should Aurora Cannabis (TSX:ACB) Stock Be on Your 2020 Buy List?

The meltdown in the shares prices of Canadian marijuana stocks is attracting contrarian investors searching for potential big winners in 2020. Pot stocks are now trading near their 12-month lows, after a rough earnings season that saw many of the companies scale back revenue projections amid ongoing challenges in the recreational market. The rollout of legal recreational pot in Canada…

Read More

Will Cronos (TSX:CRON) Stock Move Higher After a 25% Decline Last Week?

Shares of leading cannabis company Cronos Group (TSX:CRON)(NASDAQ:CRON) fell over 25% in the last week. Why did Cronos Group investors lose a quarter of their market value in the week ended on November 15, 2019? Cronos Group announced its third-quarter results on November 12 and reported sales of $12.7 million — 238% higher compared to sales of $3.76 million in…

Read More

Another Week in Red for Cannabis Investors as Earnings Disappoint

Cannabis investors continued to experience a massive decline in share prices for the last week ended on November 15, 2019. Leading cannabis stocks such as Aurora Cannabis (TSX:ACB)(NYSE:ACB), Canopy Growth, and Hexo lost market value in the last week. While Canopy Growth stock fell 26.7%, Aurora Cannabis and Hexo lost 27.6% and 22.5%, respectively, in the last week. Horizons Marijuana…

Read More

Canopy Growth (TSX:WEED) Earnings Drag Cannabis Stocks Lower

Shares of Canada’s leading cannabis company Canopy Growth (TSX:WEED)(NYSE:CGC) fell 14.5% yesterday after it announced fiscal second quarter of 2020 (year ending in March) results. In the September quarter, Canopy Growth reported sales of $76.6 million, a year-over-year growth of 228% compared to sales of $23.33 million in the prior-year period. The company’s earnings per share improved from -$1.52 to…

Read More